Headquarters
2401 4TH AVE STE 1050, SEATTLE, WA 98121-3460, US
SEATTLE, WA, US
From the company
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for the treatment of cancer. The company leverages its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.
2401 4TH AVE STE 1050, SEATTLE, WA 98121-3460, US
Quantities, certifications, and timing.